Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 38 Carcinoma, Non-Small-Cell Lung 30 Esophageal Squamous Cell Carcinoma 22 Carcinoma, Hepatocellular 21 Triple Negative Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Breast Neoplasms 17 Advanced Solid Tumor 17 Stomach Neoplasms 14 Melanoma 14 Uterine Cervical Neoplasms 12 Colorectal Neoplasms 12 Small Cell Lung Carcinoma 11 Neoplasms 10 Carcinoma, Transitional Cell 10 Recurrence 9 Carcinoma, Renal Cell 9 Solid Tumor 7 Sarcoma 7 Neoplasm Metastasis 7 Liver Neoplasms 7 Head and Neck Neoplasms 7 Rectal Neoplasms 5 Esophageal Neoplasms 5 Advanced Solid Tumors 5 Urinary Bladder Neoplasms 4 Pancreatic Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Cholangiocarcinoma 4

Interventions

Fulvestrant 18 Letrozole 8 Anastrozole 6 Capecitabine 5 palbociclib 4 olaparib 4 Docetaxel 4 pyrotinib 3 exemestane 3 Paclitaxel 3 Goserelin 3 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 abemaciclib 2 Vinorelbine 2 Trastuzumab 2 Injections 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1 trastuzumab deruxtecan 1 toripalimab 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡